Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh
· Delayed Price · Currency is BDT 103.10
-0.90 (-0.87%)
At close: Apr 29, 2026
Beacon Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 1,238 | 946.51 | 521.01 | 509.84 | 935.04 | 863.17 | Upgrade
|
| Depreciation & Amortization | 631.4 | 631.4 | 527.78 | 518.92 | 439.7 | 385.16 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 6.5 | -3.07 | - | - | Upgrade
|
| Other Operating Activities | -93.32 | 153.83 | 287.23 | -147.1 | 438.72 | 75.87 | Upgrade
|
| Change in Accounts Receivable | -50.52 | -50.52 | -767.59 | -251.01 | -30.72 | -873.78 | Upgrade
|
| Change in Inventory | -435.6 | -435.6 | -895.97 | -19.73 | -693.28 | -246.07 | Upgrade
|
| Change in Accounts Payable | -236.31 | -236.31 | 680.87 | 191.87 | -7.83 | 183.53 | Upgrade
|
| Change in Income Taxes | - | - | - | - | -169.84 | 162.23 | Upgrade
|
| Change in Other Net Operating Assets | 590.71 | 590.71 | -539.46 | -178.55 | 170.39 | -353.56 | Upgrade
|
| Operating Cash Flow | 1,644 | 1,600 | -179.63 | 621.18 | 1,082 | 196.56 | Upgrade
|
| Operating Cash Flow Growth | -10.38% | - | - | -42.60% | 450.56% | -32.49% | Upgrade
|
| Capital Expenditures | -917.14 | -821.53 | -1,095 | -1,814 | -1,719 | -313.41 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.72 | 0.24 | 30.15 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.2 | -1.2 | -25.22 | - | - | - | Upgrade
|
| Investment in Securities | 333.38 | -194.48 | -1,276 | -2,190 | -118.52 | -403.71 | Upgrade
|
| Other Investing Activities | -19.96 | - | -0 | 39.83 | - | 3.24 | Upgrade
|
| Investing Cash Flow | -604.2 | -1,017 | -2,366 | -3,965 | -1,838 | -713.87 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 1,529 | 349.06 | Upgrade
|
| Long-Term Debt Issued | - | - | 2,864 | 3,628 | - | - | Upgrade
|
| Total Debt Issued | - | - | 2,864 | 3,628 | 1,529 | 349.06 | Upgrade
|
| Long-Term Debt Repaid | - | -241.8 | - | - | -199.71 | -33.27 | Upgrade
|
| Total Debt Repaid | -423.7 | -241.8 | - | - | -199.71 | -33.27 | Upgrade
|
| Net Debt Issued (Repaid) | -423.7 | -241.8 | 2,864 | 3,628 | 1,330 | 315.79 | Upgrade
|
| Common Dividends Paid | - | -347.11 | -369.56 | -371.06 | -373.53 | -59.42 | Upgrade
|
| Other Financing Activities | 22.81 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | -400.9 | -588.9 | 2,494 | 3,257 | 956.25 | 256.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | -25.55 | -73.24 | -93.69 | - | - | - | Upgrade
|
| Net Cash Flow | 613.34 | -79.09 | -145.24 | -86.31 | 200.66 | -260.94 | Upgrade
|
| Free Cash Flow | 726.84 | 778.5 | -1,275 | -1,193 | -637.07 | -116.85 | Upgrade
|
| Free Cash Flow Margin | 4.92% | 6.21% | -11.91% | -14.02% | -7.94% | -1.64% | Upgrade
|
| Free Cash Flow Per Share | 3.15 | 3.37 | -5.52 | -5.17 | -2.76 | -0.51 | Upgrade
|
| Cash Interest Paid | 1,339 | 1,327 | 983.91 | 464.36 | 339.38 | 166.8 | Upgrade
|
| Cash Income Tax Paid | 137.74 | 255.15 | 257.56 | 271.77 | 450.75 | 17.31 | Upgrade
|
| Levered Free Cash Flow | -535.29 | -8.61 | -3,111 | -3,814 | -1,146 | -562.04 | Upgrade
|
| Unlevered Free Cash Flow | 294.06 | 809.17 | -2,484 | -3,526 | -934.37 | -459.03 | Upgrade
|
| Change in Working Capital | -131.72 | -131.72 | -1,522 | -257.42 | -731.28 | -1,128 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.